Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Fugger

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
European Journal of Immunology|December 28, 2020
Characterization of T-cell receptor transgenic mice recognizing immunodominant HLA-DQ2.5-restricted gluten epitopesChristian B Lindstad, Shuo-Wang Qiao, Marie K Johannesen, et al.
Nature Immunology|February 28, 2003
The nature of molecular recognition by T cellsSimon J Davis, Shinji Ikemizu, Edward J Evans, et al.
The American Journal of Pathology|December 25, 2007
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosisJohn S Tzartos, Manuel A Friese, Matthew J Craner, et al.
Neuron|November 22, 2011
Activation of central orexin/hypocretin neurons by dietary amino acidsMahesh M Karnani, John Apergis-Schoute, Antoine Adamantidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2012
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritisJoshua D Ooi, Janet Chang, Michael J Hickey, et al.
The American Journal of Pathology|February 2, 2011
IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brainJohn S Tzartos, Matthew J Craner, Manuel A Friese, et al.
BMJ Open|November 11, 2015
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trialJustin B McKee, John Elston, Nikos Evangelou, et al.
Nature Immunology|January 29, 2002
Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBPBénédicte Manoury, Daniela Mazzeo, Lars Fugger, et al.
The Lancet. Neurology|January 20, 2017
Severe B-cell-mediated CNS disease secondary to alemtuzumab therapyAiden Haghikia, Calliope A Dendrou, Ruth Schneider, et al.
Nature Medicine|November 13, 2007
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous systemManuel A Friese, Matthew J Craner, Ruth Etzensperger, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
European Journal of Immunology|December 28, 2020
Characterization of T-cell receptor transgenic mice recognizing immunodominant HLA-DQ2.5-restricted gluten epitopesChristian B Lindstad, Shuo-Wang Qiao, Marie K Johannesen, et al.
Nature Immunology|February 28, 2003
The nature of molecular recognition by T cellsSimon J Davis, Shinji Ikemizu, Edward J Evans, et al.
The American Journal of Pathology|December 25, 2007
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosisJohn S Tzartos, Manuel A Friese, Matthew J Craner, et al.
Neuron|November 22, 2011
Activation of central orexin/hypocretin neurons by dietary amino acidsMahesh M Karnani, John Apergis-Schoute, Antoine Adamantidis, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2012
The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritisJoshua D Ooi, Janet Chang, Michael J Hickey, et al.
The American Journal of Pathology|February 2, 2011
IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brainJohn S Tzartos, Matthew J Craner, Manuel A Friese, et al.
BMJ Open|November 11, 2015
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trialJustin B McKee, John Elston, Nikos Evangelou, et al.
Nature Immunology|January 29, 2002
Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBPBénédicte Manoury, Daniela Mazzeo, Lars Fugger, et al.
The Lancet. Neurology|January 20, 2017
Severe B-cell-mediated CNS disease secondary to alemtuzumab therapyAiden Haghikia, Calliope A Dendrou, Ruth Schneider, et al.
Nature Medicine|November 13, 2007
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous systemManuel A Friese, Matthew J Craner, Ruth Etzensperger, et al.
Pageof 12